MedTrace Logo

Enabling the Study of Metabolism in Breast Cancer Through Collection of Fresh-tissue Biopsies

NCT03880097 · Status: NOT_YET_RECRUITING · Type: OBSERVATIONAL · Enrollment: 240

Last updated 2019-03-19

No results posted yet for this study

Summary

This study aims to evaluate how breast cancer cells metabolise nutrients in order to grow. Patients enrolled into this study will undergo a research biopsy that will aim to collect up to 4 cores of tumour tissue. These tissues will then be used in translational research to analyse how specific pro-tumorigenic events change breast cancer cell metabolism (compared to healthy cell metabolism).

Conditions

Interventions

PROCEDURE

Research Biopsy

The "Research Biopsy" is a biopsy in addition to the standard of care biopsies that the patient will have to inform their diagnosis. The actual procedure is not any different to the standard per-cutaneous biopsy, this is just an additional procedure, solely for research purposes.

Sponsors & Collaborators

  • University College, London

    lead OTHER

Principal Investigators

  • Neill Patani, MD · University College London Hospitals

  • Jayant Vaidya, MD · The Whittington Hospital

  • Michael Douek, MD · Guy's and St Thomas' NHS Foundation Trust

  • Amna Sherri, MD · Royal Free London NHS Foundation Trust

  • Laura Johnson, MD · Barts & The London NHS Trust

  • Robert Price, MD · King's College Hospital NHS Trust

Eligibility

Min Age
18 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2019-04-01
Primary Completion
2022-02-28
Completion
2027-02-28

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03880097 on ClinicalTrials.gov